Phase 4
N=133
Interactions Between Drug Effects and Environments II
Substance-Related Disorders
Bottom Line
View on ClinicalTrials.gov: NCT03075501 ↗Enrolled (actual)
133
Serious AEs
6.0%
Results posted
May 2021
Primary outcome: Primary: Change in Time Spent in Drug-paired Room — 24.5; 6.2 seconds
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Paired (Behavioral); Stimulant or sedative (Drug); Placebo (Drug)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Illinois at Chicago
- Primary completion
- Jul 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Time Spent in Drug-paired Room |
24.5; 6.2 | — |
| SECONDARY Subjective Drug Effects |
3.4; 4.1 | — |
Summary
The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.
Eligibility Criteria
Inclusion Criteria
- past use of stimulants
- bmi 19-26
- hormonal birth control for women
Exclusion Criteria
- current or recent (Past year) history of major axis I disorder
Data sourced from ClinicalTrials.gov (NCT03075501). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.